US Patent Issued to UNIWERSYTET JAGIELLONSKI, LIPID SYSTEMS SP. Z on Sept. 15 for "MRI contrast agent for use in the diagnosis of early changes in the endothelium of blood vessels" (Polish Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,256, issued on Sept. 15, was assigned to UNIWERSYTET JAGIELLONSKI (Cracow, Poland) and LIPID SYSTEMS SP. Z O.O. (Wroclaw, Poland).

"MRI contrast agent for use in the diagnosis of early changes in the endothelium of blood vessels" was invented by Anna Bar (Przemysl, Poland), Tomasz Borowik (Cracow, Poland), Stefan Chlopicki (Cracow, Poland), Marek Langner (Wroclaw, Poland) and Magdalena Przybylo (Wroclaw, Poland).

According to the abstract* released by the U.S. Patent & Trademark Office: "MRI contrast agent for use in the diagnosis of early changes in the endothelium of blood vessels."

The patent was filed on March 11, 2020, under Application No. 17/433,657.

*For further inform...